Trial intelligence / Profile preview

DIVINEO: Dexmedetomidine vs Placebo in Premature Neonates Receiving Invasive Ventilation

NCT07493785Phase 3Not yet recruiting

Sponsor
Centre Hospitalier Intercommunal de Créteil
Start
Jan 2027
Primary completion
Jan 2033
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in neonatal respiratory failure, pain, Infant discomfort, sponsored by Centre Hospitalier Intercommunal de Créteil. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

neonatal respiratory failurepainInfant discomfort

Beyond the preview

Go deeper on NCT07493785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07493785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call